Bisoprolol — Membership Pricing

Related medications

Other medications associated with the same conditions in this catalog.

Also listed for Hypertension

• Amlodipine
• Atenolol
• Carvedilol
• Diltiazem
• Furosemide
• Hydrochlorothiazide
• Lisinopril
• Losartan

Other medications in Heart & Cardiovascular

• Bosentan
• Bumetanide
• Candesartan
• Cangrelor
• Captopril
• Chlorthalidone
• Cholestyramine
• Colesevelam

About Bisoprolol

Bisoprolol is a widely prescribed medication crucial for managing various heart conditions, including high blood pressure and angina. For many, accessing essential prescriptions like bisoprolol can be a financial burden. Fortunately, TheDrugClub is dedicated to making vital medications affordable and accessible, ensuring our members can get the care they need without compromise.

Bisoprolol, often prescribed under brand names like Zebeta, is a beta-blocker primarily used to treat high blood pressure (hypertension), angina (chest pain), and certain types of heart failure. By reducing the heart's workload, it helps improve blood flow and prevent serious cardiovascular events, contributing significantly to long-term cardiovascular health.

How Bisoprolol Works

As a selective beta-1 adrenergic blocker, bisoprolol works by blocking the effects of certain natural chemicals in your body, like adrenaline, on your heart and blood vessels. This action causes your heart to beat more slowly and with less force, effectively lowering blood pressure and reducing the heart's oxygen demand. It also helps relax blood vessels, further contributing to improved circulation throughout the body. This precise mechanism makes bisoprolol a cornerstone treatment for maintaining stable cardiovascular function and preventing complications associated with heart disease.

Understanding Typical Costs

The cost of bisoprolol can vary significantly depending on factors such

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Bisoprolol is approved for (FDA label)

BISOPROLOL FUMARATE TABLETS, USP are indicated in the management of hypertension. It may be used alone or in combination with other antihypertensive agents.

Source: Read the full FDA label on DailyMed. Label effective date: April 21, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Bisoprolol (FDA label)

Safety data are available in more than 30,000 patients or volunteers. Frequency estimates and rates of withdrawal of therapy for adverse events were derived from two U.S. placebo-controlled studies. In Study A, doses of 5, 10, and 20 mg bisoprolol fumarate were administered for 4 weeks. In Study B, doses of 2.5, 10, and 40 mg of bisoprolol fumarate were administered for 12 weeks. A total of 273 patients were treated with 5 to 20 mg of bisoprolol fumarate; 132 received placebo. Withdrawal of therapy for adverse events was 3.3% for patients receiving bisoprolol fumarate and 6.8% for patients on placebo. Withdrawals were less than 1% for either bradycardia or fatigue/lack of energy.

Source: FDA prescribing information (DailyMed). Set ID: df37d337-9978-0c31-e053-2a95a90a3258. SPL document ID: 4ffb30c3-c812-9e7e-e063-6294a90a24b2. Label effective date: April 21, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Bisoprolol (FDA label)

BISOPROLOL FUMARATE is contraindicated in patients with cardiogenic shock, overt cardiac failure, second or third degree AV block, and marked sinus bradycardia.

Source: FDA prescribing information (DailyMed). Set ID: df37d337-9978-0c31-e053-2a95a90a3258. SPL document ID: 4ffb30c3-c812-9e7e-e063-6294a90a24b2. Label effective date: April 21, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Drug interactions for Bisoprolol (FDA label)

BISOPROLOL FUMARATE should not be combined with other beta-blocking agents. Patients receiving catecholamine-depleting drugs, such as reserpine or guanethidine, should be closely monitored, because the added beta-adrenergic blocking action of BISOPROLOL FUMARATE may produce excessive reduction of sympathetic activity. In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that BISOPROLOL FUMARATE be discontinued for several days before the withdrawal of clonidine. BISOPROLOL FUMARATE should be used with care when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists (particularly of the phenylalkylamine [verapamil] and benzothiazepine [diltiazem] classes), or antiarrhythmic agents, such as disopyramide, are used concurrently. Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate. Concomitant use can increase the risk of bradycardia.

Source: FDA prescribing information (DailyMed). Set ID: df37d337-9978-0c31-e053-2a95a90a3258. SPL document ID: 4ffb30c3-c812-9e7e-e063-6294a90a24b2. Label effective date: April 21, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.